Jpmorgan Chase & CO Retractable Technologies Inc Transaction History
Jpmorgan Chase & CO
- $1.27 Trillion
- Q1 2025
A detailed history of Jpmorgan Chase & CO transactions in Retractable Technologies Inc stock. As of the latest transaction made, Jpmorgan Chase & CO holds 28 shares of RVP stock, worth $18. This represents 0.0% of its overall portfolio holdings.
Number of Shares
28
Previous 31
9.68%
Holding current value
$18
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
10 transactions
Others Institutions Holding RVP
# of Institutions
31Shares Held
2.31MCall Options Held
15.5KPut Options Held
200-
Vanguard Group Inc Valley Forge, PA690KShares$461,9710.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny360KShares$240,9600.0% of portfolio
-
Black Rock Inc. New York, NY274KShares$183,5630.0% of portfolio
-
Bridgeway Capital Management, LLC Houston, TX156KShares$104,2720.0% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il153KShares$102,4850.0% of portfolio
About RETRACTABLE TECHNOLOGIES INC
- Ticker RVP
- Exchange NYSE
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 32,937,200
- Market Cap $22.1M
- Description
- Retractable Technologies, Inc. designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession in the United States, rest of North and South America, and internationally. It offers VanishPoint insulin syringes; tuberculin, insulin, and allergy antigen syringes; small diameter tube adap...